CEOS logo

Psykey, Inc. Stock Price

OTCPK:CEOS Community·US$939.2k Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

CEOS Share Price Performance

US$0.003
-0.02 (-83.87%)
US$0.003
-0.02 (-83.87%)
Price US$0.003

CEOS Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks
0 Rewards

Psykey, Inc. Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$5.0m

Other Expenses

-US$5.0m

Earnings

Last Reported Earnings
Sep 30, 2008
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About CEOS

Founded
2002
Employees
n/a
CEO
Michael Maher
WebsiteView website
www.psykeyworld.com

Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market. Its retail products include functional mushroom coffees and teas, oral supplements, and single serve drink mixes. The company was formerly known as CeCors, Inc. and changed its name to Psykey, Inc. in August 2021. The company was incorporated in 2002 and is based in Toronto, Canada.

Recent CEOS News & Updates

Recent updates

No updates